"Radiation Pneumonitis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Inflammation of the lung due to harmful effects of ionizing or non-ionizing radiation.
Descriptor ID |
D017564
|
MeSH Number(s) |
C08.381.483.675 C08.381.520.734 C26.733.762 G01.750.748.500.762
|
Concept/Terms |
Radiation Pneumonitis- Radiation Pneumonitis
- Pneumonitides, Radiation
- Radiation Pneumonitides
- Pneumonitis, Radiation
- Radiation Pneumonia
- Pneumonia, Radiation
- Pneumonias, Radiation
- Radiation Pneumonias
|
Below are MeSH descriptors whose meaning is more general than "Radiation Pneumonitis".
Below are MeSH descriptors whose meaning is more specific than "Radiation Pneumonitis".
This graph shows the total number of publications written about "Radiation Pneumonitis" by people in this website by year, and whether "Radiation Pneumonitis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2005 | 1 | 0 | 1 |
2010 | 0 | 1 | 1 |
2011 | 1 | 0 | 1 |
2012 | 1 | 0 | 1 |
2013 | 0 | 1 | 1 |
2014 | 1 | 0 | 1 |
2018 | 1 | 0 | 1 |
2019 | 0 | 1 | 1 |
2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Radiation Pneumonitis" by people in Profiles.
-
Radiation Recall Pneumonitis: Imaging Appearance and Differential Considerations. Korean J Radiol. 2024 Sep; 25(9):843-850.
-
Biomarkers associated with pulmonary exacerbations in a randomized trial of nintedanib for radiation pneumonitis. Radiother Oncol. 2024 07; 196:110320.
-
An 18F-FDG PET/CT and Mean Lung Dose Model to Predict Early Radiation Pneumonitis in Stage III Non-Small Cell Lung Cancer Patients Treated with Chemoradiation and Immunotherapy. J Nucl Med. 2024 Apr 01; 65(4):520-526.
-
Pneumonitis After Concurrent Chemoradiation and Immune Checkpoint Inhibition in Patients with Locally Advanced Non-small Cell Lung Cancer. Clin Oncol (R Coll Radiol). 2023 10; 35(10):630-639.
-
Randomized Phase 2 Placebo-Controlled Trial of Nintedanib for the Treatment of Radiation Pneumonitis. Int J Radiat Oncol Biol Phys. 2023 08 01; 116(5):1091-1099.
-
Personalized mid-course FDG-PET based adaptive treatment planning for non-small cell lung cancer using machine learning and optimization. Phys Med Biol. 2022 09 13; 67(18).
-
Acute and Late Pulmonary Effects After Radiation Therapy in Childhood Cancer Survivors: A PENTEC Comprehensive Review. Int J Radiat Oncol Biol Phys. 2024 Jun 01; 119(2):533-548.
-
The PRO-ACTIVE trial protocol: a randomized study comparing the effectiveness of PROphylACTic swallow InterVEntion for patients receiving radiotherapy for head and neck cancer. BMC Cancer. 2021 Oct 13; 21(1):1100.
-
Clinical and Dosimetric Predictors of Radiation Pneumonitis in Patients With Non-Small Cell Lung Cancer Undergoing Postoperative Radiation Therapy. Pract Radiat Oncol. 2021 Jan-Feb; 11(1):e52-e62.
-
Safety of thoracic radiotherapy in patients with prior immune-related adverse events from immune checkpoint inhibitors. Ann Oncol. 2020 12; 31(12):1719-1724.